Investors in And Biotech

Joint Journey, founded by Sergey Dashkov, is a dynamic investment firm launched in 2016. With a robust portfolio exceeding 120 companies and investments totaling $43M, they focus on diverse sectors such as Big Data, FinTech, New Energy, VR, IoT, and BioTech. Known for their rapid and informed investment approach, ULTRA.VC empowers founders with operational autonomy while also serving as a founding partner of AngelsDeck Global Ventures, facilitating syndicate co-investments with over 500 active angel investors.

Trois I Investissements Industriels Internationaux sa is an independent, family owned holding company focused on long term investments. ‍ Established in the late ‘90s in London, Trois I moved to Luxembourg in 2006, with the aim to take advantage of the country’s potential as an EU based financial platform.

Eyos Capital distinguishes itself as a proactive investment fund specializing in early-stage technology ventures characterized by robust intellectual property. With a hands-on approach, Eyos Capital actively supports promising companies poised for growth and innovation. Their investment strategy centers on identifying and nurturing startups with defensible technological advantages, aiming to position them as leaders in their respective fields. Eyos Capital's portfolio reflects their commitment to fostering entrepreneurial success through strategic guidance and operational support. By leveraging their expertise and network, Eyos Capital plays a pivotal role in accelerating the development and market entry of disruptive technologies, contributing to the evolution of the global tech landscape.

Medi Ventures is a seed investment VC fund with US capital investing in Poland. Our company is active in the area of Health Care, MedTech and BioTech. We support techological projects with a global market potential.

BOLD is the strategic venture capital fund of L'Oréal. We invest in brands, technology, and biotech & green science that are redefining the frontier of beauty.